Aurora Cannabis (NYSE:) was one of the first Canadian cannabis companies to accept the truth. The Canadian cannabis market is not nearly as large as the early data suggested. It’s still quite large but at today’s valuation only half of what it should be. And that led the company to make some hard decisions. Decisions that are still impacting the company today and have it set up for profits next quarter. Yes, that’s right, we have a Canadian Cannabis on the verge of profitability.
Aurora Cannabis Beats The Consensus, Loss Grows
Aurora Cannabis beat the consensus for revenue by 670 basis points to deliver a slight improvement on a QoQ basis. The $67.81 million (Canadian) beat the consensus by $4.22 million on mixed results in the underlying businesses. The Canadian Consumer segment saw its revenue fall -3.0% while the more lucrative Medical segment grew 4% on strength in International markets. The International Medical segment grew 41% from the prior quarter on strength in…
Original Author Link click here to read complete story..
